Synthetic inhibitors of the multicatalytic proteinase complex (proteasome) - PubMed (original) (raw)
Synthetic inhibitors of the multicatalytic proteinase complex (proteasome)
S Wilk et al. Enzyme Protein. 1993.
Abstract
Synthetic inhibitors of the multicatalytic proteinase complex (proteasome) can provide the means to uncover the functional significance and catalytic mechanism of this macromolecule. Although inhibitor development is still in its early stages, some useful compounds have already been prepared. Of the various types of inhibitors thus far studied, peptidyl aldehydes have been the most effective. Since peptidyl aldehydes inhibit both serine and cysteine proteinases, lack of specificity is their major limitation. The properties of one such compound N-benzyloxycarbonyl-IE(Ot-Bu)A-Leucinal, a potent inhibitor of suc-LLVY-MCA hydrolysis, are described in detail.
Similar articles
- Characterization of the active site of human multicatalytic proteinase.
Mason RW. Mason RW. Biochem J. 1990 Jan 15;265(2):479-84. doi: 10.1042/bj2650479. Biochem J. 1990. PMID: 2302179 Free PMC article. - The multicatalytic proteinase complex.
Rivett AJ. Rivett AJ. Revis Biol Celular. 1989;20:113-23. Revis Biol Celular. 1989. PMID: 2700095 Review. - Proteasome inhibitors and antigen presentation.
Bogyo M, Gaczynska M, Ploegh HL. Bogyo M, et al. Biopolymers. 1997;43(4):269-80. doi: 10.1002/(SICI)1097-0282(1997)43:4<269::AID-BIP2>3.0.CO;2-T. Biopolymers. 1997. PMID: 9316392 Review.
Cited by
- Modulators of the activation of the proteasome by PA28 (11S reg).
Wilk S, Chen WE, Magnusson RP. Wilk S, et al. Mol Biol Rep. 1999 Apr;26(1-2):39-44. doi: 10.1023/a:1006955904443. Mol Biol Rep. 1999. PMID: 10363645 - From bortezomib to other inhibitors of the proteasome and beyond.
Buac D, Shen M, Schmitt S, Kona FR, Deshmukh R, Zhang Z, Neslund-Dudas C, Mitra B, Dou QP. Buac D, et al. Curr Pharm Des. 2013;19(22):4025-38. doi: 10.2174/1381612811319220012. Curr Pharm Des. 2013. PMID: 23181572 Free PMC article. Review. - Biochemical properties of insect and crustacean proteasomes.
Mykles DL. Mykles DL. Mol Biol Rep. 1997 Mar;24(1-2):133-8. doi: 10.1023/a:1006867825811. Mol Biol Rep. 1997. PMID: 9228294 Review. No abstract available. - Inhibition of hepatitis B virus replication by interferon requires proteasome activity.
Robek MD, Wieland SF, Chisari FV. Robek MD, et al. J Virol. 2002 Apr;76(7):3570-4. doi: 10.1128/jvi.76.7.3570-3574.2002. J Virol. 2002. PMID: 11884582 Free PMC article. - Targeting the ubiquitin pathway for cancer treatment.
Liu J, Shaik S, Dai X, Wu Q, Zhou X, Wang Z, Wei W. Liu J, et al. Biochim Biophys Acta. 2015 Jan;1855(1):50-60. doi: 10.1016/j.bbcan.2014.11.005. Epub 2014 Dec 4. Biochim Biophys Acta. 2015. PMID: 25481052 Free PMC article. Review.